Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study
By March, 2023, 54 countries, areas, and territories (hereafter CAT) in the WHO European Region had reported more than 2·2 million COVID-19-related deaths to the WHO Regional Office for Europe.
Article
Scientific Papers
News
Uncovering the Contrasts and Connections in PASC: Viral Load and Cytokine Signatures in Acute COVID-19 versus Post-Acute Sequelae of SARS-CoV-2 (PASC)
The recent global COVID-19 pandemic has had a profound and enduring impact, resulting in substantial loss of life.
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December 2020 to March 2023: a retrospective surveillance study
Over nearly 2.5 years, most lives saved by COVID-19 vaccination were in older adults by first booster dose and during the Omicron period, reinforcing the importance of up-to-date vaccination among the most at-risk individuals.
Enough already: T cell inflammation and SARS-CoV-2 virus persist in Long Covid
It is estimated that 6% of American adults currently suffer from persistent symptoms that can linger for weeks to years after COVID-19 infection.
COVID-19 health information system assessments in eight European countries: identified gaps, best practices and recommendations
Global threats, such as the coronavirus disease 2019 (COVID-19) pandemic, have highlighted the critical importance of robust and well-functioning health information systems (HIS) in effectively addressing public health emergencies.
Inconsistent Increase in Age at Respiratory Syncytial Virus Hospitalization of Children Aged 2 Years During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: A Retrospective Multicenter Study in 4 European Countries
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic disrupted respiratory syncytial virus (RSV) seasonality.
Vaccination reduces central nervous system IL-1β and memory deficits after COVID-19 in mice
Up to 25% of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit postacute cognitive sequelae.
First encounter with SARS-CoV-2: immune portraits of COVID susceptibility
More than four years after the start of the COVID-19 pandemic, and the mass mobilization of the scientific community.
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited
|
9th Influenza Conference 2023
Scientific highlights of the 9th ESWI Influenza Conference
With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.
News
Policy & Recommendations
WHO Europe launches the first Pan-European Network for Disease Control
Hosted by UKHSA and initially chaired by Dame Jenny Harries, the new Network will strengthen disease surveillance and outbreak response across the European Region
